Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food and Drug ...

The new PREVENT tool may put certain groups into higher risk categories. Learn whether you should talk to your doctor about ...

Cardiologist Andrew P. Ambrosy, MD, MPH, today walked through the updated cholesterol treatment guidelines, the first rewrite since 2018. The headline for patients, he said, comes down to three shifts ...

A new study by investigators from Mass General Brigham finds that nearly 1 in 3 U.S. adults without heart disease—and almost ...

The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown.

New cholesterol guidelines advise doctors to begin screening and treating people in their 30s, long before the risks of a heart attack and stroke become significantly higher. For the first time, the ...

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.

The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...

In an updated set of guidelines, the AHA and ACA advise more aggressive cholesterol management and earlier intervention. Image credit: Riza Azhari/Getty Images Recently, the American Heart Association ...

Adults with obesity in high-income countries now have blood-pressure and cholesterol levels far closer to those of their ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...